JPMORGAN CHASE & CO - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is and the CUSIP is 15117B952. A total of 3 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2021$5,448,000
-28.4%
141,0000.0%0.00%0.0%
Q3 2021$7,613,000141,0000.00%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q1 2022
NameSharesValueWeighting ↓
PURA VIDA INVESTMENTS, LLC 100,000$2,696,0000.16%
GROUP ONE TRADING, L.P. 93,900$2,532,0000.00%
SIMPLEX TRADING, LLC 87,400$2,356,0000.00%
JANE STREET GROUP, LLC 200,900$5,416,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders